Atlas Venture Fund X L.P. 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:14 pm Purchase | 2022-12-29 | 13D | Gemini Therapeutics, Inc. GMTX | Atlas Venture Fund X L.P. | 2,237,303 12.900% | 1,835,799 (+457.23%) | Filing |
| 2021-02-16 5:25 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | Atlas Venture Fund X L.P. | 401,505 8.900% | 401,505 (New Position) | Filing |